Posted in | News | Mining Business

Madison Renews EPL-7011 at Madison North Uranium Project

Madison Metals Inc. has announced the extension of Exclusive Prospecting License 7011 (EPL-7011) in the Madison North project area, which is next to the world-famous Rössing Uranium Mine in Namibia’s famed Erongo uranium province. Madison’s portfolio benefits from this renewal because the company owns an 85% stake in EPL-7011, which is located in a well-known uranium belt.

Image Credit: Mr. Tempter/Shutterstock.com

EPL-7011 bolsters Madison’s strategic land positioning and there is an NI 43-101 technical report, affirming the license’s potential for uranium deposits. This report, alongside the renewal and the previously obtained Environmental Clearance Certificate, underlines Madison’s commitment to responsible exploration and development.

Duane Parnham, Executive Chairman and Chief Executive Officer, Madison Metals Inc.

He added, “The strategic renewal of EPL-7011, supported by an NI 43-101 technical report, aligns with our focused approach in maintaining and expanding our presence in this uranium-rich area. Our current efforts are centered on strategic exploration and drilling for potential deposit expansions on adjoining concessions.”

Madison Metals maintains its cautious approach, ensuring that exploration and development efforts are consistent with environmental stewardship and stakeholder value. The company is committed to strategically advancing its uranium assets with the goal of increasing shareholder value through prudent and environmentally aware exploration.

The renewal of EPL-7011 comes on the heels of the successful transfer of Exclusive Prospecting Licences 8531 (EPL-8531) and 8115 (EPL-8115) to PennyWort Investments (Pty) Ltd, which is held by Madison (85%) and the company’s Namibian partners (15%). Madison’s news release dated June 6th, 2023 showed the EPL-8531 and EPF-8115 license transfers.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.